Your browser doesn't support javascript.
loading
Mass versus personalized medicine against COVID-19 in the "system sciences" era.
Teodori, Laura; Osimani, Barbara; Isidoro, Ciro; Ramakrishna, Seeram.
Afiliación
  • Teodori L; Laboratory of Diagnostics and Metrology, ENEA, Rome, Italy.
  • Osimani B; Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.
  • Isidoro C; Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
  • Ramakrishna S; Department of Mechanical Engineering, National University of Singapore, Singapore, Singapore.
Cytometry A ; 101(12): 995-999, 2022 12.
Article en En | MEDLINE | ID: mdl-35716116
ABSTRACT
The importance of personalized/precision medicine for targeted therapies and improved outcomes both in terms of efficacy and safety in health care is by now grounded. We here discuss the current landscape of personalized medicine approaches against SARS-CoV-2. A schematic of the approach is illustrated in the figure in the text.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Medicina de Precisión / COVID-19 Límite: Humans Idioma: En Revista: Cytometry A Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Medicina de Precisión / COVID-19 Límite: Humans Idioma: En Revista: Cytometry A Año: 2022 Tipo del documento: Article País de afiliación: Italia